Literature DB >> 17869207

Optical coherence tomography findings in persistent diabetic macular edema: the vitreomacular interface.

Nicola G Ghazi1, Jessica B Ciralsky, Syed M Shah, Peter A Campochiaro, Julia A Haller.   

Abstract

PURPOSE: To assess the optical coherence tomography (OCT) characteristics of eyes with persistent clinically significant diabetic macular edema (PDME) after focal laser treatment, with emphasis on the vitreomacular interface (VMI) characteristics.
DESIGN: Prospective, observational case series.
METHODS: Fifty eyes with PDME after at least one focal laser treatment were enrolled prospectively. Slit-lamp biomicroscopy, stereoscopic fundus photography, fluorescein angiography (FA), and OCT were performed for each eye. The main outcome measures included the detection rate of VMI abnormalities (VMIA) by OCT in comparison with biomicroscopy, fundus photography, and FA (traditional techniques); the relationship between VMIA and the number of focal laser sessions per eye and FA leakage pattern.
RESULTS: Two of 50 eyes were excluded because of incomplete data. For the remaining 48 eyes, 25 eyes (52.1%) demonstrated definite VMIA, including anomalous vitreal adhesions, epiretinal membrane (ERM), or both, and six eyes (12.5%) had questionable VMIA. OCT in general was 1.94 times more sensitive than traditional techniques combined in detecting VMIA (P = .00003). The number of focal laser sessions and diffuse FA leakage were not associated with an increased prevalence of VMIA (P = .13 and P = .47, respectively).
CONCLUSIONS: This study demonstrates a high prevalence of VMIA in eyes with PDME after focal laser treatment and underscores the superiority of OCT in detecting these abnormalities. OCT evaluation of eyes with PDME may be helpful in identifying VMIA, which may impact treatment selection and patient subgroup stratification.

Entities:  

Mesh:

Year:  2007        PMID: 17869207     DOI: 10.1016/j.ajo.2007.07.012

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  17 in total

1.  Qualitative and quantitative OCT response of diffuse diabetic macular oedema to macular laser photocoagulation.

Authors:  R Vemala; S Koshy; S Sivaprasad
Journal:  Eye (Lond)       Date:  2011-04-15       Impact factor: 3.775

2.  Spectral domain optical coherence tomography study of macular microhole morphology and its correlation with vitreomacular interface abnormalities.

Authors:  Batmanabane Prakash Vaishnavi; Unnikrishnan Nair; Manoj Soman; K G R Nair
Journal:  Int Ophthalmol       Date:  2013-08-09       Impact factor: 2.031

3.  Quantitative assessment of macular contraction and vitreoretinal interface alterations in diabetic macular edema treated with intravitreal anti-VEGF injections.

Authors:  Ebru Nevin Cetin; Önder Demirtaş; Nihal Cesur Özbakış; Gökhan Pekel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-20       Impact factor: 3.117

4.  The incidence and risk factors for the development of vitreomacular interface abnormality in diabetic macular edema treated with intravitreal injection of anti-VEGF.

Authors:  C-K Chang; C-K Cheng; C-H Peng
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

5.  Association of fluorescein angiographic features with visual acuity and with optical coherence tomographic and stereoscopic color fundus photographic features of diabetic macular edema in a randomized clinical trial.

Authors:  Ronald P Danis; Ingrid U Scott; Haijing Qin; Michael M Altaweel; Neil M Bressler; Susan B Bressler; David J Browning; Craig Kollman
Journal:  Retina       Date:  2010 Nov-Dec       Impact factor: 4.256

6.  Optical coherence tomography imaging for diabetic retinopathy and macular edema.

Authors:  John C Buabbud; Motasem M Al-latayfeh; Jennifer K Sun
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

7.  Factors associated with diabetic macular edema in patients with proliferative diabetic retinopathy.

Authors:  John R O'Fee; Joseph Juliano; Andrew A Moshfeghi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-02-22       Impact factor: 3.117

8.  Predicting visual outcomes for macular disease using optical coherence tomography.

Authors:  Pearse A Keane; Srinivas R Sadda
Journal:  Saudi J Ophthalmol       Date:  2011-01-26

9.  Reduced effect of anti-vascular endothelial growth factor agents on diabetics with vitreomacular interface abnormalities.

Authors:  Dan Yoon; Irene Rusu; Irene Barbazetto
Journal:  Int Ophthalmol       Date:  2013-11-22       Impact factor: 2.031

10.  Evidence for diffuse central retinal edema in vivo in diabetic male Sprague Dawley rats.

Authors:  Bruce A Berkowitz; David Bissig; Yongquan Ye; Puja Valsadia; Timothy S Kern; Robin Roberts
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.